Quarterly report pursuant to Section 13 or 15(d)

Stockholders' equity

v3.24.3
Stockholders' equity
 9 Months Ended
Sep. 30, 2024
Stockholders' equity  
Stockholders' equity

Note 12 — Stockholders’ equity

On April 8, 2022 the Company entered into a sales agreement with Cowen (the “Sales Agreement”) under which we may from time to time issue and sell American Depositary Shares (ADSs) representing our ordinary shares through Cowen in “at-the-market” offerings (“ATM”) for an aggregate offering price of up to $200 million. In the nine months ended September 30, 2024 the Company sold 27,278,176 ADSs under the Sales Agreement representing 163,669,056 ordinary shares resulting in net proceeds to the Company of $29,155,317 after deducting commissions payable under the Sales Agreement and issuance costs. As of September 30, 2024, approximately $156,228,841 remained available for sale under the Sales Agreement.

​

​